The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction
Abstract
The sympathetic overdrive that characterizes essential hypertension is potentiated when left ventricular hypertrophy or congestive heart failure is detected. No information exists, however, on whether this is the case also for left ventricular diastolic dysfunction. In 17 untreated hypertensive subjects with left ventricular diastolic dysfunction (age: 47.7±2.9 years, mean±SEM), we measured sympathetic nerve traffic (microneurography), heart rate (ECG), and beat-to-beat arterial blood pressure (Finapres) at rest and during baroreceptor deactivation and stimulation. Data were compared with those collected in 20 age-matched normotensive and 20 hypertensive subjects without a diastolic function impairment. Muscle sympathetic nerve traffic values were markedly and significantly greater in the 2 hypertensive groups than in the normotensive one (55.3±1.2 and 71.2±1.6 versus 41.7±1.0 bursts per 100 heartbeats, respectively; P <0.01 for both). For a similar blood pressure elevation, however, the sympathetic nerve traffic increase was significantly greater in patients with than without left ventricular diastolic dysfunction (+28.9%; P <0.05). In the population as a whole, muscle sympathetic nerve traffic was significantly and inversely related to various echocardiographic indices of diastolic function. Although baroreflex-heart rate control was significantly attenuated in the 2 hypertensive groups, baroreflex-sympathetic modulation was impaired only in those with diastolic dysfunction. These data provide the first evidence that, in hypertension, activation of the sympathetic nervous system may contribute not only at the blood pressure elevation but also at the development of left ventricular diastolic dysfunction. The sympathetic overactivity, which is likely to be related to the baroreflex impairment, may account for the increased cardiovascular risk characterizing diastolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adrenergic neural factors may also contribute to the development and progression of target organ damage, as documented by the pronounced increase in sympathetic nerve traffic and cardiac norepinephrine spillover rate in patients in which hypertension is complicated by left ventricular hypertrophy or left ventricular diastolic dysfunction40,42,44,45.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [45]
Experimental — accuracy not yet measuredIn the citing paper
“As far as the second issue is concerned, microneurographic studies almost universally shown that sympathetic nerve traffic is potentiated in established hypertension in middle age and in elderly as well as young patients38–46.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Self-citationRecommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
Self-citationEchocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
SIMONE, G. D., Devereux, R. B., Roman, M. J., Ganau, A., Saba, P. S., Alderman, M. H., & Laragh, J. H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90390-5 · Cited by 604
Hjemdahl, P., Daleskog, M., & Kahan, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90384-9 · Cited by 564
Aurigemma, G. P., Gottdiener, J. S., Shemanski, L. R., Gardin, J. M., & Kitzman, D. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01110-x · Cited by 528
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526
Self-citation
Cited by
Sorted by citations
Items 101–194 of 194
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights
Grassi, G. M., Brambilla, G., Pizzala, D. P., & Seravalle, G. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0667-0 · Cited by 10
Self-citationSympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I
Safaryan, A. S., & Sargsyan, V. D. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2693 · Cited by 12
Sympathetic nervous system and arterial hypertension: new perspectives, new data
Hering, D., & Narkiewicz, K. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0089 · Cited by 10
Dimitriadis, K. S., Iliakis, P., Vakka, A., Pyrpyris, N., Pitsillidi, A., Tsioufis, P., Fragkoulis, C., Hering, D., Weil, J., Κόλλιας, Α., et al. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000850 · Cited by 9
Cardiac Autonomic Drive during Arterial Hypertension and Metabolic Disturbances
Ксенева, С. И., Бородулина, Е. В., Trifonova, O. Y., & Удут, В. В. (2016) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-016-3385-3 · Cited by 9
The Role of the Autonomic Nervous System in Cardiovascular Toxicity
Carll, A. P., Farraj, A. K., & Roberts, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64259-9 · Cited by 9
Victor, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00045-7 · Cited by 9
Bunsawat, K., Skow, R. J., Kaur, J., & Wray, D. W. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00214.2023 · Cited by 8
Nakashima, H., Shinohara, K., Matsumoto, S., Nakashima, R., Yoshida, D., Ono, Y., Miyamoto, R., Ikeda, S., Matsushima, S., Hashimoto, T., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-02025-7 · Cited by 8
Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure
Floras, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10016-6 · Cited by 8
Sigurdardottir, F. D., Lyngbakken, M. N., Hveem, K., Hrubos‐Strøm, H., Røsjø, H. R., Redline, S. S., & Omland, T. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13299 · Cited by 9
Rosendorff, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126177 · Cited by 8
Renal denervation in the setting of heart failure
Koppe-Schmeißer, F., Fengler, K., Kresoja, K., Lurz, P. C., & Rommel, K. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10489-z · Cited by 8
Groban, L., Wang, H., Machado, F. S. M., Trask, A. J., Kritchevsky, S. B., Ferrario, C. M., & Diz, D. I. (2012) · Cardiovascular Endocrinology · doi:10.1097/xce.0b013e32835a2159 · Cited by 7
Makowski, K., Gielerak, G. G., Kramarz, E., Wierzchoń, S. T., Kamiński, G., Kowal, J., Krzesiński, P., Żegadło, A., & Skrobowski, A. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.10 · Cited by 7
Cui, J. G., Drew, R. C., Muller, M. D., Blaha, C., Gonzalez, V., & Sinoway, L. I. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00293.2018 · Cited by 7
Paulino, E. T. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102480 · Cited by 6
Tanındı, A., Olgun, H., Çelik, B., & Boyacı, B. (2012) · Future Cardiology · doi:10.2217/fca.12.24 · Cited by 6
Efficacy of baroreflex activation therapy for the treatment of resistant hypertension
Briasoulis, Α., & Bakris, G. L. (2013) · EuroIntervention · doi:10.4244/eijv9sra23 · Cited by 6
Genetics of systolic and diastolic heart failure
Deng, A. Y. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000400 · Cited by 6
Floras, J. S., & Mak, S. S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp239 · Cited by 6
Indole-3 Acetate Limits Dysbiosis-Driven Diastolic Failure via Hcrt Neurons
Zakarauskas-Seth, B. I., Forcari, G., Anandakumar, H., Kotlar-Goldaper, I., Barraud, C. M., Jovanović, N. D., Brüning, U., Kirwan, J., Wilck, N., Forslund, S. K., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326990 · Cited by 5
Zohora, F. T., Nazari, M. A., & Sinusas, A. J. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02197-9 · Cited by 5
Sympathetic drive stimulating diastolic dysfunction?
Ahmad, S. S., & Gerson, M. C. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0809-z · Cited by 5
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
Kristensen, A. M. D., Pareek, M., Olsen, M. H., & Bhatt, D. L. (2020) · US Cardiology Review · doi:10.15420/usc.2019.13.2 · Cited by 5
Urbancsek, R., Csanádi, Z., Forgács, I. N., Papp, T. B., Boczán, J., Barta, J., Jenei, C., Nagy, L., & Rudas, L. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13580 · Cited by 4
Sympatho-Vagal Imbalance in Hypertension
Grassi, G. M., & Seravalle, G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00071-8 · Cited by 5
Self-citationEffects of Blood Pressure Control in Cardiovascular Prevention
Artom, N., Vecchié, A., & Pende, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160822145446 · Cited by 5
Jareebi, M. A. (2025) · Diagnostics · doi:10.3390/diagnostics15162097 · Cited by 5
Neuromodulation of the Failing Heart
Byku, M., & Mann, D. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00019-4 · Cited by 4
Higashihara, T., Fukuda, Y., Nakano, T., Takeda, A., Morita, Y., Ono, M., Watanabe, N., Sada, Y., Ikenaga, H., Utsunomiya, H., et al. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02257-6 · Cited by 4
Clinical Applications of Microneurography
Mano, T. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00081-0 · Cited by 4
Renal Denervation to Modify Hypertension and the Heart Failure State
Zhong, M., Kim, L. K., Swaminathan, R. V., & Feldman, D. N. (2017) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.03.013 · Cited by 4
Boutagy, N. E., & Sinusas, A. J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186130 · Cited by 3
Renal Denervation: Past, Present, and Future
Pourafshar, N., Karimi, A., Anderson, R. D., Alaei-Andabili, S. H., & Kandzari, D. E. (2016) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2016.0016 · Cited by 3
Li, S., & Li, X. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00341-5 · Cited by 3
Harishkaruppiah, R. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104983 · Cited by 2
Cheng, H., Yeh, C., Wu, C., Chen, M. Y., Chang, Y., Tsai, H.-H., Chen, Z.-W., Lee, H.-C., Pan, H., Hsu, R.-Y., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.09.040 · Cited by 2
Makowski, K., Kramarz, E., Kamiński, G., Grzęda, M., Kramarz, P., & Kade, G. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1306538 · Cited by 2
Ambulatory autonomic nervous system activity in relation to hearing impairment
Huizinga, N. A., Keur‐Huizinga, L., van de Ven, S. R. B., van Dijk, W., Versfeld, N. J., Zekveld, A. A., Kramer, S. E., & de Geus, E. J. C. (2024) · Psychophysiology · doi:10.1111/psyp.14723 · Cited by 2
Teixeira, A. L. D. S. (2019) · The Journal of Physiology · doi:10.1113/jp278174 · Cited by 2
Targeting Blood Pressure Lowering and the Sympathetic Nervous System
Hering, D., & Narkiewicz, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00027-2 · Cited by 2
Aleynikova, T. V. (2018) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2018.10.006 · Cited by 2
Wang, M., Liu, C., Shah, A., Ko, Y.-A., Lampert, R., Sun, Y. V., Moazzami, K., Garcia, M., Almuwaqqat, Z., Najarro, G. R., et al. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101694 · Cited by 1
Balcan, B., & Peker, Y. (2025) · SLEEP · doi:10.1093/sleep/zsaf225 · Cited by 1
Bi̇rgün, A., Çelik, M. C., Kalçık, M., Yetim, M., Bekar, L., & Karavelioğlu, Y. (2025) · Exploration of Cardiology · doi:10.37349/ec.2025.101283 · Cited by 1
Autonomic dysfunction in patients with wild-type transthyretin amyloidosis
Kleinveld, V. E. A., Wanschitz, J., Hotter, A., Horlings, C. G. C., Leys, F., Ungericht, M., Pölzl, G., Granata, R., Fanciulli, A., & Löscher, W. N. (2026) · Journal of Neurology · doi:10.1007/s00415-025-13604-0 · Cited by 1
Analysis of Autonomic Nervous System Functional Age and Heart Rate Variability in Mine Workers
Vasicko, T., Prindesova-Busikova, J., & Osina, O. (2016) · Acta Medica Martiniana · doi:10.1515/acm-2016-0003 · Cited by 1
Gilyarevsky, S. R. (2014) · Systemic Hypertension · doi:10.26442/sg29059 · Cited by 1
Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension
Yang, Y., Xu, J., Shu, S., Wang, P., Liang, Y., Liu, B., Yang, B., Zhang, H., Zhao, Q., Zhao, Z., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02856-7 · Cited by 1
Sympathetic Activity in Hypertension and Heart Failure
Hering, D., Seravalle, G., Grassi, G. M., & Narkiewicz, K. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-39315-0_8 · Cited by 1
Self-citationNeuroadrenergic abnormalities in hypertension and hypertension-related cardiovascular disease
Grassi, G. M. (2013) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2013.03.001 · Cited by 1
Self-citationSeravalle, G., Brambilla, G., Pizzala, D. P., & Grassi, G. M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_6 · Cited by 1
Self-citationGrassi, G. M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836541ae · Cited by 1
Self-citationMasuo, K., & Gavin, W. (2012) · InTech eBooks · doi:10.5772/50523
Renale Sympathikusdenervation bei therapierefraktärer arterieller Hypertonie
Brandt, M. C., & Hoppe, U. C. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0447-2
Comparing autonomic and cardiovascular responses in African and Caucasian men : the SABPA study
Uys, L. (2012) · Boloka Institutional Repository (North-west University)
Sometimes you simply have to wait
Jordan, J., & Grassi, G. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328353e104
Self-citationNeurogenic and Non-neurogenic Mechanisms of White-Coat Hypertension
Grassi, G. M., Seravalle, G., & Dell’Oro, R. (2014) · Springer eBooks · doi:10.1007/978-3-319-07410-8_3
Self-citationRenke, M. (2009)
Paulo, S., de Cardiologia, P., & Consolim‐Colombo, F. M. (2011)
cardiogenic pulmonary injury Autonomic activation links CNS oxygen toxicity to acute
It, D., Zhilyaev, S. Y., Moskvin, A. N., Piantadosi, C. A., & Barry, W. H. (2016)
Assessment and Mechanisms of Autonomic Function in Health and Disease
Pellegrino, P. R. (2016) · DigitalCommons@UNMC
Louridas, G. E., Butler, J., Triposkiadis, F. K., Karayannis, G., Giamouzis, G., & Skoularigis, J. S. (2009)
Chawla, S., Singhal, R., & Guchhait, P. (2014) · Journal of Hypertension and Cardiology · doi:10.14302/issn.2329-9487.jhc-14-edt3
Abo‐Salem, E. (2016) · Archives of Clinical Hypertension · doi:10.17352/ach.000007
Brito, L. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.39.2018.tde-06092018-145236
Dutta, S., & Mukherjee, K. (2018) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2018.09.105
The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
Конради, А. О., Ратова, Л. Г., Emelyanov, I. V., & Недошивин, А. О. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-11-96-99
The Role of Statins in the Management of Heart Failure with Preserved Ejection Fraction
Alkagiet, S., Giannakoulas, G. A., Hatzitolios, A. I., & Τζιόμαλος, Κ. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00172-x
Hypotensive Syndromes and Heart Failure
Alagiakrishnan, K., Mah, D., & Ahmed, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30332-7_12
Pyndiura, K. (2020) · TSpace (University of Toronto)
Hering, D., Seravalle, G., Grassi, G. M., & Narkiewicz, K. (2019) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93320-7_5
Self-citationSeravalle, G., Grassi, G. M., & Mancia, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95897-5
Self-citationKato, T., Sato, W., Sato, T., Shimizu, H., & Watanabe, H. (2022) · Cardiology Research · doi:10.14740/cr1402
Autonomic Dysfunction in Hypertension
Parati, G., & Ochoa, J. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-43036-7_3 · Cited by 1
Hering, D., & Heuser, R. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-38934-4_17
Targeting Blood Pressure Lowering and the Sympathetic Nervous System
Hering, D., & Narkiewicz, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00013-1
The coming era of neuromodulation therapies: expectations for baroreceptor stimulation
Shinohara, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01781-w
Exploring the Role of Prefrontal Cortex tDCS in Hypertension: A Mini-Review
Ruberti, O. M., Moreno, H., & Rodrigues, B. (2024) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x343701241113100959
Neves, P. P., Ferreira, M. J., Shecaira, T. P., Dutra, M. R. H., Kimura, D. C., Gomes, G. N., & Angelis, K. D. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00168
The Role of the Autonomic Nervous System in Cardiovascular Toxicity
Carll, A. P., Reynolds, B. R., & Roberts, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00263-1
Novel model of cardiac hypertrophy with cardiorenal dysfunction
Silva, A. D. A., Jensen, L., Marques, J. R., Nascimento‐Carvalho, B., de Souza, L. E., da Silva, M. B., Moreira, N. J. D., Veras, M. M., Waked, D., Souza, F. L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-90435-z
Hypertension Unraveled: From Mechanisms to Modern Management
Fatima, S. N., Saeed, F. U., & Sana, M. (2025) · doi:10.38124/ijisrt/25sep335
Yang, Y., Xu, J., Shu, S., Wang, P., Liang, Y., Liu, B., Yang, B., Zhang, H., Zhao, Q., Zhao, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26668479
Yang, Y., Xu, J., Shu, S., Wang, P., Liang, Y., Liu, B., Yang, B., Zhang, H., Zhao, Q., Zhao, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25010357
Yang, Y., Xu, J., Shu, S., Wang, P., Liang, Y., Liu, B., Yang, B., Zhang, H., Zhao, Q., Zhao, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25010507
Grzeczka, A.-M., Pinkowska, K., Nawrocka, W. K., Korbel, Z., Taciak, Z., Jaszowski, M., Michalska, I., Dąbrowska, A., Pietraszkiewicz, P., Żak, P., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5545
Jo, S.-G., & Jee, Y. (2026) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2652192.096
Neural Control of Tissue Perfusion: Emerging Evidence and Beyond
Colombari, E., Pedrino, G. R., Katayama, P. L., Zoccal, D. B., Mendonça, M. M., Colombari, D. S. A., & Xavier, C. H. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01378-3
Metadata
- Authors
- Grassi, G., Seravalle, G., Quarti-Trevano, F., Dell'Oro, R., Arenare, F., Spaziani, D., & Mancia, G.
- Affiliations
- IRCCS Istituto Auxologico Italiano (IT)
- From the Clinica Medica (G.G., F.Q-T., R.D., F.A., G.M.), Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Ospedale San Gerardo, Milan, Italy; Istituto Auxologico Italiano (G.G., G.S., G.M.), Milan, Italy; and the Divisione di Cardiologia (D.S.), Ospedale di Legnano, Legnano, Italy.
- Venue
- Hypertension
- Published
- 2009-02
- Volume
- 53
- Issue
- 2
- Pages
- 205-209
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2122749049
- Cited by
- 194
- References
- 40
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 13 · 2023: 11 · 2022: 10 · 2021: 3 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 11 · 2016: 16 · 2015: 10 · 2014: 11 · 2013: 13 · 2012: 20
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- essential hypertension, left ventricular diastolic dysfunction, sympathetic nervous system, baroreflex, muscle sympathetic nerve activity, baroreflex sensitivity, rate control, cardiovascular risk, sympathetic hyperactivity
- MeSH terms
- Adult, Blood Pressure, Cardiac Output, Cardiovascular Physiological Phenomena, Heart Rate, Heart Ventricles, Humans, Hypertension, Male, Middle Aged, Stroke Volume, Sympathetic Nervous System, Echocardiography, Doppler, Case-Control Studies, Baroreflex, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
